DuBois, PA / / September 12, 2025 / Highroad Enterprises Key Takeaways StemWave acoustic wave therapy offers a non-invasive ...

Orthocell (ASX:OCC) has flagged rapid “hockey stick” revenue growth as the nerve repair device innovator’s early US ...

According to a recent report published by Mordor Intelligence, the duodenoscopes market is valued at USD 1.61 billion in 2025 ...

Prurigo Nodularis market to exhibit growth at a CAGR of 23.2% (2020-2034), driven by strong uptake of DUPIXENT, recent approval of NEMLUVIO, promising JAK and OX40 inhibitors in the Pipeline, along ...

Perth-based regenerative medicine company Orthocell (ASX:OCC) has announced its flagship nerve repair device Remplir has been introduced to urologists in Australia for use in nerve-sparing ...

Diabetes is one of the most common conditions in the world and is associated with a broad range of adverse effects in multiple organ systems. Roughly half of all patients with diabetes will develop a ...

Peripheral nerve impairments in older adults were tied to a higher risk of subsequent dementia, a study of longitudinal data showed. Combined sensory and motor impairments in the lower leg doubled the ...

PERTH, Australia, Sept. 16, 2025 /PRNewswire/ -- Regenerative medicine company Orthocell Limited (ASX:OCC, "Orthocell" or the "Company") is pleased to announce its flagship nerve repair device, ...

Neurofibromatosis type 1 (NF1) is a genetic condition that causes tumors to grow along nerves in the skin, brain, and other parts of the body. These tumors are usually noncancerous (benign), but they ...

A new study led by National Taiwan University Hospital (NTUH) researchers shows that while scarless thyroid surgery preserves ...

Dr. Noah Marchese, owner of HealthChoice Center of Peachtree City, offers a variety of treatment options for patients with peripheral neuropathy - a conditi ...

RejuvaCare introduces soothing heat, targeted massage, and adjustable compression as a drug-free path for comfort and ...